ON DEMAND
Roundtable: Integrating Proteomics & Other Omics Data for Cancer Research
Experts discuss the importance of using proteomics data in multi-omics analysis to power healthcare breakthroughs
Proteomics data has now become more readily available for researchers alongside other omics data in population health datasets. The ability to combine data on the entire set of genes and associated proteins expressed by the cell is opening new avenues for extracting insights into specific disease areas including cancer.
Learn how researchers are incorporating proteomics data into their multi-omics analysis to enable cancer research discoveries. The roundtable of expert panelists will discuss their current research projects, the impact of large-scale multi-omics data, & the technologies and strategies they use for performing multimodal analysis.
Please fill out the form to access the on demand webinar.

Cindy Lawley, PhD
Senior Director, Population Health
Olink Proteomics
About Cindy Lawley, PhD

J. Scott Beeler, MD, PhD
Internal Medicine Resident Physician
Washington University School of Medicine | Barnes-Jewish Hospital
About J. Scott Beeler, MD, PhD

Dr. Karl Smith-Byrne
Senior Molecular Epidemiologist
Cancer Epidemiology Unit, University of Oxford
About Dr. Karl Smith-Byrne

Moderator: Ben Busby, PhD
Director of Solution Science
DNAnexus